891 related articles for article (PubMed ID: 15840033)
1. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
2. Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
Kazama I; Arata T; Michimata M; Hatano R; Suzuki M; Miyama N; Sanada S; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Nephrol Dial Transplant; 2007 Jan; 22(1):68-76. PubMed ID: 16702208
[TBL] [Abstract][Full Text] [Related]
3. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
[TBL] [Abstract][Full Text] [Related]
4. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy.
Michimata M; Fujita S; Araki T; Mizukami K; Kazama I; Muramatsu Y; Suzuki M; Kimura T; Sasaki S; Imai Y; Matsubara M
Kidney Int; 2003 Jan; 63(1):165-71. PubMed ID: 12472779
[TBL] [Abstract][Full Text] [Related]
5. Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla.
Kortenoeven ML; Sinke AP; Hadrup N; Trimpert C; Wetzels JF; Fenton RA; Deen PM
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1705-18. PubMed ID: 24154696
[TBL] [Abstract][Full Text] [Related]
6. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Wada K; Matsukawa U; Fujimori A; Arai Y; Sudoh K; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):91-5. PubMed ID: 17202666
[TBL] [Abstract][Full Text] [Related]
7. Pathological role of aquaporin-2 in impaired water excretion and hyponatremia.
Ishikawa S; Saito T; Kasono K
J Neuroendocrinol; 2004 Apr; 16(4):293-6. PubMed ID: 15089964
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin-independent renal urinary concentration: increased rBSC1 and enhanced countercurrent multiplication.
Michimata M; Mizukami K; Suzuki M; Kazama I; Nakamura Y; Suzuki K; Yanagisawa T; Imai Y; Sasaki S; Matsubara M
Kidney Int; 2003 Sep; 64(3):933-8. PubMed ID: 12911543
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats.
Kwon TH; Nielsen J; Knepper MA; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F673-84. PubMed ID: 15585668
[TBL] [Abstract][Full Text] [Related]
10. Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats.
Zhang G; Zeng X; Han L; Wei JA; Huang H
J Ethnopharmacol; 2010 Mar; 128(2):433-7. PubMed ID: 20083182
[TBL] [Abstract][Full Text] [Related]
11. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Saito T; Ishikawa S; Abe K; Kamoi K; Yamada K; Shimizu K; Saruta T; Yoshida S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1054-7. PubMed ID: 9100572
[TBL] [Abstract][Full Text] [Related]
12. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
Fujisawa G; Ishikawa S; Tsuboi Y; Okada K; Saito T
Kidney Int; 1993 Jul; 44(1):19-23. PubMed ID: 8355461
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin escape and memory impairment in a model of chronic syndrome of inappropriate secretion of antidiuretic hormone in mice.
Kawakami T; Fujisawa H; Nakayama S; Yoshino Y; Hattori S; Seino Y; Takayanagi T; Miyakawa T; Suzuki A; Sugimura Y
Endocr J; 2021 Jan; 68(1):31-43. PubMed ID: 32879162
[TBL] [Abstract][Full Text] [Related]
15. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
Ishikawa Se ; Saito T; Fukagawa A; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Honda K; Saito T
J Clin Endocrinol Metab; 2001 Apr; 86(4):1665-71. PubMed ID: 11297601
[TBL] [Abstract][Full Text] [Related]
16. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats.
Fujita N; Ishikawa SE; Sasaki S; Fujisawa G; Fushimi K; Marumo F; Saito T
Am J Physiol; 1995 Dec; 269(6 Pt 2):F926-31. PubMed ID: 8594889
[TBL] [Abstract][Full Text] [Related]
17. Single-tubule RNA-Seq uncovers signaling mechanisms that defend against hyponatremia in SIADH.
Lee JW; Alsady M; Chou CL; de Groot T; Deen PMT; Knepper MA; Ecelbarger CM
Kidney Int; 2018 Jan; 93(1):128-146. PubMed ID: 28843412
[TBL] [Abstract][Full Text] [Related]
18. Studies of renal aquaporin-2 expression during renal escape from vasopressin-induced antidiuresis.
Verbalis JG; Murase T; Ecelbarger CA; Nielsen S; Knepper MA
Adv Exp Med Biol; 1998; 449():395-406. PubMed ID: 10026831
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis.
Tian Y; Sandberg K; Murase T; Baker EA; Speth RC; Verbalis JG
Endocrinology; 2000 Jan; 141(1):307-14. PubMed ID: 10614652
[TBL] [Abstract][Full Text] [Related]
20. Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
Kamoi K
Nephron; 1997; 76(1):111-5. PubMed ID: 9171309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
